Cresco Labs, Inc. (CRLBF)
1.43
+0.65
(+83.57%)
USD |
OTCM |
Dec 12, 16:08
Cresco Labs EPS Diluted (Quarterly): -0.048 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arvinas, Inc. | -0.4795 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.97M |
| Revenue (Quarterly) | 164.91M |
| Total Expenses (Quarterly) | 181.97M |
| Enterprise Value | 692.32M |
| Gross Profit Margin (Quarterly) | 45.06% |
| Profit Margin (Quarterly) | -13.32% |
| Earnings Yield | -10.34% |
| Operating Earnings Yield | 16.67% |
| Normalized Earnings Yield | -5.587 |